MedicalResearch.com Interview with:
Prof. Dr. Ulrich Ettinger
Departments of Psychology
University of Bonn
Bonn, Germany
Medical Research: What are the main findings of the study?
Prof. Ettinger: We found that 24-hour sleep deprivation induced subjective cognitive, perceptual and emotional alterations resembling the symptoms of schizophrenia. We also observed that sleep deprivation led to a deficit in a sensorimotor filter mechanism called prepulse inhibition (PPI), similar to the disturbance seen in schizophrenia.
Vincenza Spallone MD PhD
Endocrinology and Neurology
Department of Systems Medicine
Tor Vergata University, Rome, Italy
Medical Research: What are the main findings of the study?
Dr. Spallone:To investigate a possible relationship between painful diabetic polyneuropathy (PDPN) and the circadian pattern of blood pressure (BP), we performed ambulatory blood pressure monitoring in 113 diabetic patients with PDPN, with painless diabetic polyneuropathy (DPN) and without DPN. In addition, we evaluated neuropathic pain, sleep, risk for obstructive sleep apnoea (OSA), autonomic function, and in a subgroup of patients, depressive symptoms.
The main finding was that patients with painful diabetic polyneuropathy displayed impaired nocturnal fall in BP compared to those without neuropathy, and higher nocturnal systolic blood pressure than the other two groups. Although the day-night change (∆) in blood pressure failed to reach a significant difference between painful diabetic polyneuropathy and DPN groups, nondipping (the loss of nocturnal fall in systolic BP) was more strictly associated with painful diabetic polyneuropathy than DPN and in multivariate analysis, including comorbidities and most potential confounders, neuropathic pain was an independent determinant of ∆ BP and nocturnal systolic blood pressure.
In summary, we showed a novel association of peripheral diabetic neuropathic pain with nondipping and higher systolic nocturnal blood pressure, which was not entirely explained through pain dependent sleep problems or other pain- or diabetes-related comorbidities, like CAN, OSA and depression.
MedicalResearch.com Interview with:
Nathaniel F. Watson, MD, MSc
Professor of Neurology, University of Washington
Co-director, University of Washington Medicine Sleep Center
Director, Harborview Medical Center Sleep Clinic
Seattle, Washington
MedicalResearch: What are the main findings of the study?
Dr. Watson: The Singh Index is a composite measure of socioeconomically deprived neighborhoods. We found that as Singh Index increased, sleep duration reduced. This was true in the total sample of twins, and within twin pairs. The fact that we saw this within twin pairs means the association is present after controlling for genetics and shared environment, which substantially strengthens the association.
MedicalResearch.com: Interview with:
Dr. June Chi-Yan Lo
Research Fellow
Cognitive Neuroscience Laboratory
Duke-NUS Graduate Medical School
Singapore
MedicalResearch: What are the main findings of the study?
Dr. Lo: The Duke-NUS study examined the data of 66 older Chinese adults, from the
Singapore-Longitudinal Aging Brain Study. Participants underwent
structural MRI brain scans measuring brain volume and neuropsychological
assessments testing cognitive function every two years. Additionally,
their sleep duration was recorded through a questionnaire. Those who slept
fewer hours showed evidence of faster brain aging and decline in cognitive
performance.
MedicalResearch.com Interview with:
Ronnie Fass, M.D., FACG, Professor of Medicine
Case Western Reserve University
Director, Division of Gastroenterology and Hepatology, Head, Esophageal and Swallowing Center, Metro Health Medical Center
Cleveland, OH
MedicalResearch: What are the main findings of the study?
Dr. Fass: This is the first study to compare the extent of acid reflux between nighttime sleep and daytime naps in patients with Gastroesophageal reflux disease. The results of our study show that naps are associated with significantly greater esophageal acid exposure compared to sleep. Acid reflux events were more frequent and their total duration was longer during naps when compared with acid reflux events during nighttime sleep. Additionally, the fraction of time that the subjects were experiencing acid reflux with pH < 4 was significantly higher during naps than nighttime sleep and subjects experienced more symptoms due to acid reflux during their nap than their sleep.
MedicalResearch.com Interview with:
Julio A. Chirinos, MD, PhD
Assistant Professor of Medicine
Director, CTRC Cardiovascular Phenotyping Unit
Perelman School of Medicine, University of Pennsylvania
Director of Non-Invasive Imaging
Philadelphia VA Medical Center
MedicalResearch: What are the main findings of the study?
Dr. Chirinos: The main findings of the study is that, among patients with obesity and moderate to severe obstructive sleep apnea, obesity, rather than OSA, appears to be the primary cause of inflammation, insulin resistance and dyslipidemia. However, both obesity and obstructive sleep apnea appear to be causally related to hypertension. In this population, weight loss, but not CPAP, can be expected to reduce the burden of inflammation, insulin resistance and dyslipidemia. However, CPAP, among patients who comply with therapy, can be expected to provide a significant incremental benefit on blood pressure. The latter is an important potential benefit of CPAP and should not be disregarded.
MedicalResearch.com Interview with:
Tetyana Kendzerska MD, PhD
Postdoctoral Fellow
Institute for Clinical Evaluative Science,
Sunnybrook Health Sciences Center, Toronto, ON
MedicalResearch: What are the main findings of the study?
Dr. Kendzerska: Based on a large sample of more than 8,500 participants with suspected sleep apnea, our study shows that among people with obstructive sleep apnea (OSA), and controlling for risk factors for diabetes development, initial OSA severity predicted risk for incident diabetes. Measures of the physiologic consequences of OSA (e.g., low level of oxygen, sleep deprivation) were also risk factors for diabetes in this population.
MedicalResearch.com Interview with: Lois E. Krahn, M.D. Sleep Disorders Center Mayo Clinic, Arizona MedicalResearch: What are the main findings of the study? Dr. Krahn: Patients are now more likely now to own multiple pets rather than a single dog or cat. Data from other sources (like the pet products group) confirm the same trend. MedicalResearch: Were...
MedicalResearch.com Interview with:
Elizabeth Devore, ScD
Associate Epidemiologist
Brigham and Women’s Hospital
Instructor in Medicine, Harvard Medical School
MedicalResearch.com: What are the main findings of the study?
Dr. Devore: In this study, we examined sleep duration and memory performance in a group of ~15,000 women participating in the Nurses’ Health Study. We found that women with sleep durations of 5 or fewer hours/day or 9 or more hours/day, either in midlife or later life, had worse memory at older ages than those sleeping 7 hours/day. In addition, women with sleep durations that changed by two or more hours/day from midlife to later life performed worse on memory tests compared to those whose sleep duration did not change during that time period.The magnitude of these memory differences was approximately equivalent to being 1-2 years older in age.
MedicalResearch.com Interview with: Prof. Dr. Bernd Schultes Endocrinology and Diabetes Internal Medicine eSwiss Medical & Surgical Center Brauerstrasse 97 9016 St. Gallen Schweiz MedicalResearch.com: What are the main findings of the study? Professor Schultes: Sleep loss promotes the development of obesity and diabetes by metabolic and behavioral mechanism. MedicalResearch.com: Were any of the findings unexpected? Professor Schultes:...
MedicalResearch.com Interview with:
Dr. Vincent Yi-Fong Su
Department of Chest Medicine
Taipei Veterans General Hospital
Taipei, Taiwan
MedicalResearch.com: What are the main findings of the study?
Answer: We found interestingly that patients with sleep apnea experienced a 1.20-fold (95% CI, 1.10-1.31; p <0.001) increase in incident pneumonia compared to patients without sleep apnea. We also demonstrated an “exposure-response relationship,” in that the patients with more severe sleep apnea might have a higher risk for pneumonia than did those of milder severity.
MedicalResearch.com Interview with:
Dr Abi Fisher PhD
Senior Researcher, Cancer Research UK
Health Behaviour Research Centre
University College London
MedicalResearch.com: What are the main findings of the study?
MedicalResearch.com Interview:
Dr. John McBeth
Arthritis Research UK Primary Care Centre
Keele University in Staffordshire
MedicalResearch.com: What are the main findings of the study?
Dr. McBeth: In this study, reporting musculoskeletal pain was common with just under half of participants reporting some pain and one quarter reporting widespread pain. Of those who were free of WP at baseline, 19% reported new onset widespread pain at three year follow up.
In addition to osteoarthritis, sleep, cognitive impairment, anxiety and physical health independently predicted the onset of widespread pain and are important treatment targets. In this study non-restorative sleep was the strongest predictor of new onset widespread pain. Sleep is a modifiable target that could improve outcome in this patient group.
Matthew Buman PhD
School of Nutrition and Health Promotion, Arizona State University
Arizona State University, School of Nutrition and Health Promotion
Phoenix, AZ
MedicalResearch.com: What are the main findings of the study?
Dr. Buman: We found that that exercise at night (within 4 hours of bedtime) was not associated with poor sleep compared with individuals that did not exercise before bed. However, we also found that morning exercise appears to be associated with optimal sleep quality.
MedicalResearch.com Interview with:
David Gozal, MD
The Herbert T. Abelson Professor and Chair
Department of Pediatrics
Physician-in-Chief, Comer Children's Hospital
The University of Chicago Chicago, IL 60637
MedicalResearch.com: What are the main findings of the study?
Dr. Gozal: Our study shows that in children with mild obstructive apnea, treatment with an anti-inflammatory combination of 2 medications, namely nasal corticosteroid and oral montelukast is associated with favorable outcomes in the vast majority of the children. Thus, rather than pursue treatment with adenotonsillectomy as is currently the case in most places, this study paves the way for non-surgical alternative therapies in pediatric OSA.
MedicalResearch.com Interview with:
Jonathan Cedernaes PhD
Department of Neuroscience
Uppsala University Sweden
MedicalResearch.com: What are the main findings of this study?
Dr. Cedernaes: We found that two peripheral blood markers were modestly but significantly increased in healthy young participants after a single night of sleep deprivation, as compared with a normal night of sleep. These two markers, S-100B and NSE, are for example used as markers of acute ischemic injury in the brain, and are also increased following concussions. S-100B is produced mainly by glial cells and also increases after injury to the blood brain barrier. NSE is instead produced by neurons and is regarded as being more specific for neuronal damage, although it can also be produced by peripheral cells.
MedicalResearch.com Interview Invitation with:
Dr. Peter Lindenauer MD MS
Director, Center for Quality of Care Research
Baystate Medical Center, Springfield, MA, US
MedicalResearch.com: What are the main findings of the study?
Answer: Among a cohort of 250,000 patients hospitalized for pneumonia at 347 US hospitals, those with a diagnosis of obstructive sleep apnea were twice as likely to be intubated at the time of hospital admission than patients without sleep apnea. In addition, patients with sleep apnea had approximately 50% higher risk of needing to be transferred to the ICU after initial admission to a regular bed, and a 70% increased risk of requiring intubation later in the hospital stay. Patients with sleep apnea stayed longer in the hospital and incurred higher costs than those without sleep apnea.
MedicalResearch.com Interview Invitation M.E. Fenton MD MSc FRCPC FCCP Associate Professor Program Director, Respirology Training Program Division of Respirology, Critical Care and Sleep Medicine University of Saskatchewan MedicalResearch.com: What are the main findings of the study? Dr. Fenton: This study demonstrates that asking a simple question in the outpatient clinic – Does your bed-partner ever poke or...
MedicalResearch.com Interview with:
Miranda M. Lim, MD, PhD
Assistant Professor, Sleep Medicine
Division of Pulmonary and Critical Care
Portland VA Medical Center and Oregon Health & Science University
MedicalResearch.com: What are the main findings of the study?
Dr. Lim: People with traumatic brain injury (TBI) often have persistent sleep-wake disturbances including excessive daytime sleepiness and nighttime insomnia, yet the link between a hard blow to the head and drowsiness remains a mystery. We report that a dietary supplement containing branched chain amino acids helps keep mice with TBI awake and alert. The findings suggest that branched chain amino acids, something all humans produce from foods in their normal diets, could potentially alleviate sleep problems associated with TBI. In experiments with brain-injured mice that had trouble staying awake, we found that feeding the animals a dietary supplement enriched with branched chain amino acids improved wakefulness. Treated mice not only stayed continuously awake for longer periods of time, they also showed more orexin neuron activation, neurons known to be involved in maintaining wakefulness. (Previous studies have shown that people with narcolepsy lose significant amounts of orexins.) Branched chain amino acids are the building blocks of neurotransmitters, the chemicals released by neurons in the brain, including glutamate and GABA. We believe that branched chain amino acids act to restore the excitability of orexin neurons after brain injury, which could potentially promote wakefulness. Further studies are needed to pinpoint the exact mechanism of branched chain amino acids effect on sleep pathways in the brain, and to determine any side effects.
MedicalResearch.com Interview with:
Dr G. Neil Thomas,
Regional Director,
NIHR Research Design Service West Midlands
Deputy Director, Master of Public Heath Programme
Reader in Epidemiology
Department of Public Health, Epidemiology and Biostatistics
School of Health and Population Sciences
College of Medical and Dental Sciences The University of Birmingham
Edgbaston, Birmingham, B15 2TT
MedicalResearch.com: What are the main findings of the study?
Dr. Thomas: This population of severely obese individuals (mean BMI 47kg/m2) from a regional specialist weight management service poor sleep quality (Pittsburgh Sleep Quality Index, PSQI) and daytime sleepiness (Epworth Sleepiness Scale) were strongly associated with poorer quality of life (Impact of Quality of Life-Lite (IWQOL-Lite)
MedicalResearch.com Interview with:
Dr. Kathryn Orzech PhD
Postdoctoral fellow,Charting the Digital Lifespan
University of Dundee, Scotland, UK
MedicalResesarch.com: What are the main findings of the study?
Dr. Orzech: We found that acute illnesses, such as colds, flu, and gastroenteritis were more common among healthy adolescents with shorter sleep. Specifically, our main analysis found that reported bouts of illness (analyzed on a bouts-of-illness-per-interview basis) declined with longer sleep for both male and female high school students. Longer sleep was also generally protective against school absences that students attributed to illness. There were sex differences, with males reporting fewer illness bouts than females, even with similar sleep durations. This is consistent with another recent study that showed a lower impact of shorter sleep on male adolescents (in that case the outcome was male adiposity), but more research is needed.
We also conducted a secondary analysis to examine total sleep time in matched 6-day windows before illness and before wellness in the same adolescents. Although the number of participants who met our strict criteria for a healthy 6-day window before illness or wellness was only 18 (I was amazed at how difficult it was to find adolescents who reported being completely well for 6 consecutive days), we were able to see a trend in the data toward shorter sleep before illness vs. wellness. Because of the difficulty in comparing sleep before illness vs. wellness, we conducted a qualitative analysis as well, choosing two 17 year old males who were both shorter sleepers, but who reported very different illness profiles - 0 days of illness vs. 35 days of illness across the school term. An in-depth look at notes made by interviewers allowed us to create brief case studies to illustrate that not all shorter sleepers are alike. More irregular sleep timing across weeknights and weekends (much shorter sleep during the week and longer sleep times on the weekend), and a preference for scheduling work and social time later in the evening hours may both contribute to differences in illness outcomes.
MedicalResearch.com Interview with:
Mohamed El Shayeb MD, MSc
Health Technology and Policy Unit
University of Alberta
3025 Research Transition Facility
Edmonton, Alberta, Canada T6G2V2
MedicalResearch.com: What are the main findings of the study?
Dr. El Shayeb: Our study shows that limited channel level-3 portable devices, used at home, are of good diagnostic value compared to the comprehensive reference-standard level-1 sleep tests conducted in lab in the diagnosis of obstructive sleep apnea (the most common subtype of sleep disordered breathing.)
Were any of the findings unexpected?
None of the findings were unexpected. Level-3 portable devices are commonly used in clinical practice; however, this technology has been widely disseminated, without solid evidence about their diagnostic performance or the subpopulation of sleep disordered breathing patients who are most appropriately diagnosed with them. Our research provides a high level of evidence on the diagnostic performance of these devices, and most importantly, defines the subgroup of patients who are eligible for this test (patients with simple obstructive sleep apnea, and without significant comorbidities.)